• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Alpha Tau Medical Ltd.

    Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Treats First Patient with Recurrent Lung Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau to Present at Upcoming November Investor Conferences
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Tickers DRTS DRTSW
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.